Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Express Scripts

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Dextrose - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for dextrose and what is the scope of patent protection?

Dextrose is the generic ingredient in one hundred and seventy-three branded drugs marketed by B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Icu Medical Inc, Miles, Hospira, Abbott, and DHL, and is included in eighty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for dextrose. Eleven suppliers are listed for this compound.

Summary for dextrose
US Patents:0
Drug Master File Entries: 9
Suppliers / Packagers: 11
Drug Prices: Drug price trends for dextrose
DailyMed Link:dextrose at DailyMed
Drug Prices for dextrose

See drug prices for dextrose

US Patents and Regulatory Information for dextrose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018876-002 Jan 17, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare DEXTROSE 30% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017521-003 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Miles DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 018400-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.